20240041510. SEGMENTAL VASCULAR ABLATION simplified abstract (Crossfire Medical Inc)

From WikiPatents
Jump to navigation Jump to search

SEGMENTAL VASCULAR ABLATION

Organization Name

Crossfire Medical Inc

Inventor(s)

Adam Tschida of Brooklyn Park MN (US)

SEGMENTAL VASCULAR ABLATION - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240041510 titled 'SEGMENTAL VASCULAR ABLATION

Simplified Explanation

The disclosed patent application describes a system for treating a vessel wall in a patient's vascular system. The system includes a controller and a sheath with an open proximal sheath end connected to the controller. The distal sheath end is designed for insertion into the patient's vascular system, and there is a working lumen that extends through the sheath.

Key points of the patent/innovation:

  • The system includes a wire that extends from the controller through the working lumen.
  • The distal end of the wire is configured to mechanically treat a vessel wall in a treatment segment.
  • The length of the distal wire end determines the length of the treatment segment.
  • The working lumen is designed to receive the wire and allow fluid to pass through for chemical treatment of the treatment segment.
  • The system can mechanically treat the vessel wall when it receives a first input and deliver fluid when it receives a second and/or third input.

Potential applications of this technology:

  • Treatment of vascular diseases such as atherosclerosis.
  • Minimally invasive procedures for removing plaque or blockages in blood vessels.
  • Targeted drug delivery to specific areas of the vascular system.

Problems solved by this technology:

  • Provides a more precise and controlled method for treating vessel walls.
  • Allows for both mechanical and chemical treatment of the treatment segment.
  • Minimizes the risk of damage to surrounding tissues.

Benefits of this technology:

  • Improved patient outcomes due to targeted and effective treatment.
  • Minimally invasive procedure reduces the need for open surgery.
  • Enhanced precision and control during the treatment process.


Original Abstract Submitted

the disclosure includes a controller and a sheath having an open proximal sheath end coupled to the controller, an open distal sheath end configured for insertion into a vascular system of a patient, and a working lumen extending through the sheath. the system may include a wire extending from the controller through the working lumen, the wire having a distal wire end configured to mechanically treat a vessel wall of a treatment segment, a length of the distal wire end defining a length of the treatment segment. the working lumen may be configured to slidably receive the wire and allow for a passage of a fluid about the wire therethrough to chemically treat the treatment segment. when the system receives a first input the distal wire end may mechanically treat the vessel wall. when the system receives a second input and/or a third input, the system may deliver the fluid.